8 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... used diabetic drugs ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... #pharmacology #overview ... #review #dosing ... #medications #comparison ... #drugs #table
A toxidrome is a syndrome (set of symptoms) caused by specific medications or toxins.

There are 5
set of symptoms) caused ... by specific medications ... barbituates, “Z-drugs ... antihistamines #Diagnosis ... #Table #Anticholinergics
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
Review of Intranasally ... Administered Medications ... of agents, uses ... #Comparison #Table ... VisualAbstract #Pharmacology
Sedative-Hypnotic Drugs
Benzodiazepines:
 - Bind to specific GABAA receptor subunits at central nervous system (CNS) neuronal synapses
Sedative-Hypnotic Drugs ... sedative-hypnotic drugs ... Sedative #Hypnotic #Drugs ... #medications #pharmacology ... #comparison #table
Erythemas Summarized
Erythema ab igne
 • A dermatosis that results from repeated exposure to heat (fires, heating
autoimmune conditions, medications ... malignancies, and drugs ... PrathitKulkarni #Erythemas #comparison ... #table #differential ... #diagnosis #dermatology
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... only if no clear cause ... Elimination (see Table ... STOP offending medications ... (review MAR)